click below
click below
Normal Size Small Size show me how
BDK Quiz #3
CNS 3-5
| Pharmacologic Category | Generic Name | Brand Name | Classification | Common Indications | Essential Knowledge |
|---|---|---|---|---|---|
| Antimanic agent | lithium (PO) | Lithobid | Bipolar disorder | Key Side Effects: tremor, acne, hypothyroidism, weight gain, polyuria, polydipsia, GI upset US Boxed Warnings: ability to promptly monitor levels is necessary Other Notes: narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic drug monitoring is recommended); avoid in pregnancy | |
| Antimigraine | sumatriptan (PO, intranasal, SQ) | Imitrex | Migraine | Key Side Effects: fatigue, somnolence, dizziness, chest tightness, paresthesias Other Notes: CI in ischemic heart disease, history of stroke or TIA, peripheral vascular disease, and uncontrolled hypertension | |
| Antimigraine | rizatriptan (PO) | Maxalt | Migraine | Key Side Effects: fatigue, somnolence, dizziness, chest tightness, paresthesias Other Notes: CI in ischemic heart disease, history of stroke or TIA, peripheral vascular disease, and uncontrolled hypertension | |
| First-generation antipsychotic | haloperidol (PO, IV, IM) | Haldol | Schizophrenia | Key Side Effects: sedation, EPS, parkinsonism, xerostomia, orthostatic hypotension, weight gain, QTc prolongation US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Second generation antipsychotic | clozapine (PO) | Clozaril | Treatment resistant schizophrenia | Key Side Effects: sedation, constipation, orthostatic hypotension, sialorrhea, hyperglycemia, weight gain, neutropenia US Boxed Warnings: may cause severe neutropenia; may cause orthostatic hypotension, bradycardia, and syncope; may cause seizures; may cause fatal myocarditis and cardiomyopathy; elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Second generation antipsychotic | aripiprazole (PO, IM) | PO/IM: Abilify; IM: Aristada | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | Key Side Effects: akathisia, restlessness, sedation, EPS, constipation, orthostatic hypotension, weight gain US Boxed Warnings: antidepressants increase the risk of suicidal thinking and behavior in children, adolescents and young adults; elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Second generation antipsychotic | quetiapine (PO) | Seroquel, Seroquel XR | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | Key Side Effects: sedation, EPS, constipation, orthostatic hypotension, weight gain US Boxed Warnings: antidepressants increase the risk of suicidal thinking and behavior in children, adolescents and young adults; elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Second generation antipsychotic | lurasidone (PO) | Latuda | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | Key Side Effects: sedation, EPS, constipation, orthostatic hypotension, weight gain US Boxed Warnings: antidepressants increase the risk of suicidal thinking and behavior in children, adolescents and young adults; elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death Other Notes: CI with strong 3A4 inhibitors and inducers | |
| Second generation antipsychotic | olanzapine (PO, IM) | Zyprexa | Schizophrenia, bipolar disorder, MDD (adjunct to antidepressants) | Key Side Effects: sedation, EPS, xerostomia, constipation, orthostatic hypotension, weight gain, hyperglycemia US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Second generation antipsychotic | risperidone (PO, IM) | PO: Risperdal IM: Risperdal Consta | Schizophrenia | Key Side Effects: sedation, EPS, xerostomia, constipation, orthostatic hypotension, weight gain, hyperglycemia US Boxed Warnings: elderly patients with dementia-related psychosis treated with antipsychotic drugs at increased risk of death | |
| Anticonvulsant | carbamazepine (PO) | Tegretol | Seizure disorders, bipolar disorder | Key Side Effects: dizziness, drowsiness, headache, ataxia, nausea, vomiting, hyponatremia US Boxed Warnings: risk of serious dermatologic reactions (including SJS and TEN) in patients with certain genetic predisposition; may cause aplastic anemia and agranulocytosis | |
| Anticonvulsant | lamotrigine (PO) | Lamictal | Seizure disorders, bipolar disorder | Key Side Effects: nausea, vomiting, somnolence, skin rash, alopecia US Boxed Warnings: risk of serious dermatologic reactions, including SJS | |
| Anticonvulsant | divalproex (valproic acid derivative) (PO) | Depakote, Depakote ER | Seizure disorders, bipolar disorder, migraine prophylaxis | Key Side Effects: drowsiness, weight gain, tremor, alopecia, thrombocytopenia, hyperammonemia US Boxed Warnings: may cause fatal hepatic failure; may cause life threatening pancreatitis; fetal toxicity | |
| Anticonvulsant | topiramate (PO) | Topamax | Seizure disorders, migraine prophylaxis | Key Side Effects: somnolence, dizziness, memory impairment, weight loss | |
| Anticonvulsant | levetiracetam (PO, IV) | Keppra | Seizure disorders | Key Side Effects: somnolence, dizziness, nausea, vomiting, weakness, asthenia, psychotic symptoms, agitation | |
| Anticonvulsant | oxcarbazepine (PO) | Trileptal | Seizure disorders | Key Side Effects: somnolence, dizziness, diplopia, nausea, vomiting, ataxia, hyponatremia | |
| Anticonvulsant | gabapentin (PO) | Neurontin | Seizure disorders, neuropathic pain | Key Side Effects: somnolence, dizziness, ataxia, fatigue, diplopia, xerostomia, blurry vision, peripheral edema, weight gain | |
| Anticonvulsant | pregabalin (PO) | Lyrica | CS-V | Seizure disorders, neuropathic pain | Key Side Effects: somnolence, dizziness, ataxia, fatigue, diplopia, xerostomia, blurry vision, peripheral edema, weight gain |
| Antianxiety agent | buspirone (PO) | Buspar | Anxiety | Key Side Effects: dizziness, drowsiness, nausea Other Notes: do not use with MAOI | |
| Benzodiazepine | alprazolam (PO) | Xanax | CS-IV | Anxiety | Key Side Effects: daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia US Boxed Warning: risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions Other Notes (lorazepam IV): parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | clonazepam (PO) | Klonopin | CS-IV | Anxiety, seizure disorders | Key Side Effects: daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia US Boxed Warning: risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions Other Notes (lorazepam IV): parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | diazepam (PO, IV) | Valium | CS-IV | Anxiety, seizure disorders, acute alcohol withdrawal | Key Side Effects: daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia US Boxed Warning: risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions Other Notes (lorazepam IV): parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | lorazepam (PO, IV) | Ativan | CS-IV | Anxiety, seizure disorders, acute alcohol withdrawal | Key Side Effects: daytime sedation, performance impairment, tolerance, dependence, anterograde amnesia, withdrawal, dizziness, ataxia US Boxed Warning: risk of profound sedation, respiratory depression, coma and death with opioids; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions Other Notes (lorazepam IV): parenteral formulation contains propylene glycol and may be associated with toxicity if used ≥ 48 hours |
| Benzodiazepine | midazolam (IV, IM) | Versed | CS-IV | Anesthesia, sedation | Key Side Effects: hypotension, apnea, bradypnea US Boxed Warning: risk of profound sedation, respiratory depression, coma and death with opioids or when used for sedation in noncritical settings; risk of abuse, misuse, and addiction; risk of dependence and withdrawal reactions; dose must be individualized; never give by rapid injection in neonates |
| Hypnotic | zolpidem (PO) | PO: Ambien, Ambien CR SL: Edluar | CS-IV | Insomnia | Key Side Effects: decreased ability to function the next morning, somnolence, headache, dizziness, xerostomia, anterograde amnesia, parasomnias US Boxed Warning: serious injuries, including death, have occurred because of complex sleep behaviors (i.e., sleepwalking, sleep driving, and engaging in other activities while not fully awake); CI in patients with history of complex sleep behaviors |
| Sleep aid | melatonin (PO) | --- | OTC | Insomnia, jet lag | Key Side Effects: drowsiness, daytime somnolence |
| Sedative, general anesthetic | propofol (IV) | Diprivan | Sedation for mechanical ventilation, procedural anesthesia, status epilepticus | Key Side Effects: bradycardia, hypotension, hypertriglyceridemia, propofol-related infusion syndrome (rare) Other Notes: formulated as a 10% lipid emulsion containing 1.1 kcal/mL | |
| Alpha2 agonist, sedative | dexmedetomidine (IV) | Precedex | Sedation for mechanical ventilation or procedures | Key Side Effects: bradycardia, hypotension Other Notes: tolerance and tachyphylaxis may occur if used longer than 24 hours |